GO:0005771 multivesicular body: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005771 multivesicular body (MVB) is an endosomal compartment whose limiting membrane invaginates to form intraluminal vesicles (ILVs), sequestering membrane proteins from the cytoplasm.
• MVB morphogenesis is driven primarily by the ESCRT machinery, which sorts ubiquitinated cargo into ILVs.
• MVBs are the source of exosomes, extracellular vesicles that mediate intercellular communication and are implicated in cancer and neurodegeneration.
• Key MVB regulators include ESCRT components (TSG101, CHMP4B, VPS4), the ESCRT-associated protein ALIX, and Tmbim1, which controls TLR4 degradation.
• Dysregulated MVB/exosome pathways contribute to non-alcoholic fatty liver disease, cancer metastasis, and neurodegenerative proteinopathies.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of MVB gene function in health and disease.
Description
The multivesicular body (MVB), annotated as GO:0005771, is a specialized endosomal compartment defined by the inward invagination of its limiting membrane to generate intraluminal vesicles (ILVs). This architecture allows the cell to sequester membrane proteins and lipids away from the cytoplasm, either for degradation in the lysosome or for release as exosomes. The MVB is therefore a central hub in endosomal sorting, protein quality control, and intercellular communication. Research into the MVB has accelerated because of its roles in cancer, metabolic disease, and neurodegeneration. The ESCRT (Endosomal Sorting Complex Required for Transport) machinery is the principal driver of MVB morphogenesis, recognizing ubiquitinated cargo and catalyzing membrane scission. Beyond ESCRT, accessory proteins such as Tmbim1 regulate MVB dynamics and cargo selection, linking MVB function to inflammatory signaling and lipid metabolism. For researchers, GO:0005771 provides a precise ontological anchor for studying endosomal sorting, exosome biogenesis, and lysosomal degradation. Understanding MVB components and assembly is essential for interpreting phenotypes in knockout, knock-in, and overexpression models, and for developing therapeutics that target vesicle trafficking.
multivesicular body At A Glance
| GO ID | GO:0005771 |
|---|---|
| GO term | multivesicular body |
| Ontology | cellular_component |
| Synonym | multivesicular endosome, MVB, MVE |
| Major function | Sorting of membrane proteins into intraluminal vesicles for degradation or exosomal release |
| Key machinery | ESCRT complexes (ESCRT-0, -I, -II, -III), VPS4, ALIX |
| Related compartment | Late endosome, lysosome, exosome |
| Disease relevance | Cancer metastasis, non-alcoholic fatty liver disease, neurodegeneration |
What Is GO:0005771?
According to the Gene Ontology, GO:0005771 multivesicular body is a type of endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm. In simpler terms, it is a cellular compartment that packages membrane proteins into small internal bubbles, either to destroy them or to release them from the cell.
Why Is multivesicular body Important in Cell Biology?
The multivesicular body is important because it controls the fate of numerous membrane receptors and signaling molecules, thereby influencing cell proliferation, differentiation, and survival. Its dysfunction is linked to cancer progression, metabolic disorders, and neurodegenerative diseases, making it a high-value target for both basic and translational research.
• MVB sorting determines whether receptors such as EGFR are degraded or recycled, affecting signaling duration.
• MVBs are the origin of exosomes, which mediate intercellular communication in cancer and immunity.
• Tmbim1, an MVB regulator, protects against non-alcoholic fatty liver disease by promoting TLR4 degradation.
• GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.
• MVB dysfunction contributes to neurodegenerative diseases through impaired clearance of aggregation-prone proteins.
• Exercise acutely regulates MVB and exosome pathways in skeletal muscle.
• MVB-like organelles mediate stimulus-regulated trafficking in olfactory cilia.
• ESCRT mutations are associated with hereditary spastic paraplegia and other neurological disorders.
• MVB components are potential biomarkers and therapeutic targets in oncology.
• CRISPR screens can identify novel MVB regulators and cargo adaptors.
Multivesicular Body: Biological Process, Cellular Component, and Molecular Function
Cargo Recognition and ESCRT-0 Recruitment
In simple terms: The cell tags proteins with ubiquitin, and ESCRT-0 recognizes these tags on the endosomal membrane.
The first step in MVB morphogenesis is the recognition of ubiquitinated cargo by ESCRT-0, which binds both ubiquitin and phosphatidylinositol 3-phosphate on the endosomal membrane. This initiates the assembly of the ESCRT machinery and concentrates cargo in microdomains that will invaginate.
ESCRT-I, -II, and -III Assembly and Membrane Scission
In simple terms: A series of protein complexes deform the membrane inward and pinch off small vesicles.
ESCRT-I and ESCRT-II bridge cargo to ESCRT-III, which forms filaments that drive membrane invagination and scission. The AAA-ATPase VPS4 disassembles ESCRT-III after scission, recycling components for further rounds. This coordinated action generates intraluminal vesicles (ILVs) within the MVB.
Formation of Intraluminal Vesicles and Cargo Sequestration
In simple terms: The inward budding creates small bubbles inside the MVB, hiding membrane proteins from the cytoplasm.
As ILVs form, membrane proteins and lipids are sequestered from the cytoplasm, effectively removing them from signaling-competent pools. This process is essential for downregulating receptors such as EGFR and for sorting proteins destined for lysosomal degradation.
MVB Fusion with Lysosome or Plasma Membrane
In simple terms: The MVB can either deliver its contents to the lysosome for destruction or fuse with the cell surface to release exosomes.
MVBs can fuse with the lysosome, where ILVs and their cargo are degraded, or with the plasma membrane, releasing ILVs as exosomes. The choice between these fates is regulated by Rab GTPases and other trafficking machinery.
Exosome Biogenesis and Secretion
In simple terms: Exosomes are the small vesicles released from MVBs that can travel to other cells.
Exosome biogenesis is closely linked to MVB formation, with ESCRT-dependent and ESCRT-independent pathways contributing to ILV cargo selection. Secreted exosomes carry proteins, lipids, and RNAs that can alter recipient cell behavior, and their production is elevated in many cancers.
Key Genes Involved in GO:0005771 multivesicular body
The following genes and proteins are central to multivesicular body (GO:0005771) biogenesis, cargo sorting, and function, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSG101 | ESCRT-I component; binds ubiquitinated cargo | Knockout blocks MVB sorting and exosome secretion |
| CHMP4B | ESCRT-III filament subunit; membrane scission | Mutations linked to cataracts and neurodegeneration |
| VPS4A | AAA-ATPase; disassembles ESCRT-III | Dominant-negative blocks MVB formation |
| VPS4B | AAA-ATPase; ESCRT recycling | Paralog of VPS4A; redundant in MVB biogenesis |
| ALIX | ESCRT-associated protein; cargo adaptor | Regulates exosome biogenesis and viral budding |
| HRS | ESCRT-0 subunit; ubiquitin-binding | Required for MVB sorting of EGFR |
| STAM1 | ESCRT-0 subunit; ubiquitin-binding | Cooperates with HRS in cargo recognition |
| Tmbim1 | MVB regulator; targets TLR4 for lysosomal degradation | Protects against NAFLD in mice and monkeys |
| GPR143 | G-protein coupled receptor; controls ESCRT-dependent exosome biogenesis | Promotes cancer metastasis |
| RAB7A | Late endosome/MVB trafficking GTPase | Regulates MVB fusion with lysosome |
| RAB27A | Exosome secretion regulator | Required for MVB docking at plasma membrane |
| CD63 | Tetraspanin; MVB and exosome marker | Used to visualize MVBs and exosomes |
| CD9 | Tetraspanin; exosome marker | Enriched on exosomes; affects cargo sorting |
| CD81 | Tetraspanin; exosome marker | Facilitates exosome uptake |
| Syntenin-1 | Cargo adaptor for exosomal sorting | Links cargo to ESCRT-III via ALIX |
| VPS36 | ESCRT-II subunit | Binds ubiquitinated cargo and ESCRT-I |
| VPS25 | ESCRT-II subunit | Essential for MVB sorting |
How Is multivesicular body Regulated?
MVB biogenesis and cargo sorting are regulated at multiple levels. The ESCRT machinery is controlled by post-translational modifications and by accessory proteins such as Tmbim1, which promotes lysosomal degradation of TLR4 and protects against non-alcoholic fatty liver disease. GPR143 modulates ESCRT-dependent exosome biogenesis and cancer metastasis. Additionally, acute exercise has been shown to regulate MVB and exosome pathway responses in skeletal muscle. Rab GTPases, including RAB7A and RAB27A, control MVB fusion with lysosomes or the plasma membrane, thereby determining cargo fate.
multivesicular body and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR143 | Cancer metastasis | Knockout melanoma cells; metastasis assay |
| Tmbim1 | Non-alcoholic fatty liver disease | Liver-specific knockout mice; NAFLD diet |
| CHMP4B | Hereditary spastic paraplegia, cataracts | Knock-in mice with patient mutations |
| TSG101 | Cancer, viral budding | Conditional knockout in tumor models |
| RAB27A | Immunodeficiency, exosome secretion defects | Knockout mice; exosome profiling |
Multivesicular Body Dysfunction in Cancer
MVB and exosome pathways are frequently dysregulated in cancer. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis, suggesting that MVB components can be therapeutic targets. Exosomes released from MVBs can transfer oncogenic signals to recipient cells, contributing to tumor progression.
Multivesicular Body and Non-Alcoholic Fatty Liver Disease
Tmbim1 acts as an MVB regulator that protects against non-alcoholic fatty liver disease by targeting TLR4 for lysosomal degradation in mice and monkeys. This highlights the MVB as a key node in inflammatory signaling and metabolic liver disease.
Multivesicular Body in Neurodegeneration
Impaired MVB sorting and ESCRT function are linked to neurodegenerative diseases, including hereditary spastic paraplegia and Alzheimer's disease, through defective clearance of aggregation-prone proteins. MVB-like organelles also mediate stimulus-regulated trafficking of olfactory ciliary transduction proteins, indicating specialized roles in sensory neurons.
From multivesicular body-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate MVB morphogenesis? | CRISPR knockout in HeLa or HEK293T cells followed by electron microscopy |
| Does a point mutation in ESCRT-III affect membrane scission? | CRISPR point mutation knock-in in cell lines; live-cell imaging |
| How does a disease-associated variant affect MVB cargo sorting? | Knock-in of the variant; ubiquitin cargo flux assays |
| Where does protein X localize within the MVB? | Tagged knock-in (e.g., GFP) and immuno-EM |
| Does overexpression of gene Y increase exosome secretion? | Stable overexpression cell lines; exosome quantification |
| Which genes are essential for MVB function? | Genome-wide CRISPR knockout library screening |
How to Study the multivesicular body Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transmission electron microscopy | MVB and ILV morphology | Visualizing MVB formation in knockout cells |
| Fluorescence microscopy | Localization of MVB markers (CD63, CD9) | Live-cell tracking of MVB dynamics |
| Exosome isolation and NTA | Exosome size and concentration | Quantifying exosome secretion after gene perturbation |
| Mass spectrometry proteomics | Protein cargo of MVBs/exosomes | Identifying sorting determinants |
| CRISPR knockout screening | Genes required for MVB function | Discovery of novel regulators |
| Ubiquitin cargo flux assay | Degradation of EGFR or other receptors | Measuring MVB sorting efficiency |
| Western blot | Protein levels of ESCRT components | Validating knockout or knockdown |
| Live-cell imaging with pH-sensitive dyes | MVB fusion with lysosome | Assessing MVB-lysosome fusion |
Electron Microscopy and Imaging
Transmission electron microscopy (TEM) is the gold standard for visualizing MVBs and ILVs, revealing their characteristic multivesicular morphology. Fluorescence microscopy of tagged markers such as CD63 can track MVB dynamics in live cells.
Proteomics and Exosome Profiling
Mass spectrometry-based proteomics of isolated exosomes can identify MVB cargo and reveal changes in sorting upon gene perturbation. Exosome isolation kits and density gradient centrifugation are commonly used to purify exosomes for downstream analysis.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens have been used to identify novel regulators of MVB biogenesis and exosome secretion. These screens can be coupled with reporter systems that measure cargo degradation or exosome release.
Biochemical Assays for ESCRT Function
In vitro membrane scission assays and ubiquitin-binding assays can dissect ESCRT component activities. Western blotting for cargo proteins (e.g., EGFR) after ESCRT perturbation measures MVB sorting efficiency.
How CRISPR Can Be Used to Study GO:0005771 multivesicular body
Knockout
CRISPR knockout of MVB genes such as TSG101 or CHMP4B abolishes ILV formation and exosome secretion, providing causal evidence for their roles. Knockout cell lines are widely used to study cargo sorting defects and to validate drug targets.
Point Mutation
Point mutations in ESCRT-III subunits or cargo adaptors can be introduced by CRISPR base editing or homology-directed repair to model disease-associated variants and dissect domain-specific functions. Such models help distinguish loss-of-function from gain-of-function mechanisms.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) into endogenous MVB genes allows visualization and immunoprecipitation of native protein complexes. Knock-in of patient mutations can recreate disease phenotypes in isogenic cell lines.
Overexpression
Overexpression of MVB regulators such as Tmbim1 or GPR143 can enhance or disrupt MVB function, revealing dose-dependent effects on exosome secretion and disease phenotypes. Overexpression models are useful for gain-of-function studies and for testing therapeutic hypotheses.
How EDITGENE Supports multivesicular body Research
Researchers studying multivesicular body-related genes often need to determine whether a candidate gene is causally involved in MVB biogenesis, cargo sorting, or exosome secretion. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for multivesicular body research.
Frequently Asked Questions About multivesicular body
What is a multivesicular body (GO:0005771)?
A multivesicular body is an endosomal compartment whose limiting membrane invaginates to form internal vesicles, sequestering membrane proteins from the cytoplasm.
What genes are involved in multivesicular body formation?
Key genes include TSG101, CHMP4B, VPS4A, VPS4B, ALIX, HRS, STAM1, and Tmbim1, among others.
What is the difference between a multivesicular body and an exosome?
The multivesicular body is the intracellular compartment; exosomes are the small vesicles released when the MVB fuses with the plasma membrane.
How is the multivesicular body involved in cancer?
MVB and exosome pathways promote cancer metastasis; GPR143 controls ESCRT-dependent exosome biogenesis and enhances metastasis.
What is the role of ESCRT in multivesicular body sorting?
ESCRT complexes recognize ubiquitinated cargo and drive membrane invagination and scission to form intraluminal vesicles.
Can CRISPR be used to study multivesicular body genes?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect MVB gene function and exosome secretion.
What diseases are associated with multivesicular body dysfunction?
Diseases include cancer, non-alcoholic fatty liver disease, and neurodegenerative disorders such as hereditary spastic paraplegia.
How can I measure multivesicular body formation?
Transmission electron microscopy and fluorescence imaging of markers like CD63 are standard methods.
What is the role of Tmbim1 in the multivesicular body?
Tmbim1 is an MVB regulator that targets TLR4 for lysosomal degradation and protects against non-alcoholic fatty liver disease.
What services does EDITGENE offer for multivesicular body research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for MVB-related genes.
Conclusion
The multivesicular body (GO:0005771) is a central organelle in endosomal sorting, protein degradation, and exosome-mediated communication. Its dysfunction is implicated in cancer, metabolic liver disease, and neurodegeneration, making it a compelling target for basic and translational research. CRISPR-based models and advanced screening technologies are accelerating the discovery of MVB regulators and their therapeutic potential.
References
- 1. Hanson PI et al.. 2012. Multivesicular body morphogenesis.. Annu Rev Cell Dev Biol 28:337-62 PMID: 22831642
- 2. Maurya DK et al.. 2022. A multivesicular body-like organelle mediates stimulus-regulated trafficking of olfactory ciliary transduction proteins.. Nat Commun 13(1):6889 PMID: 36371422
- 3. Arya SB et al.. 2024. The ins-and-outs of exosome biogenesis, secretion, and internalization.. Trends Cell Biol 34(2):90-108 PMID: 37507251
- 4. Hessvik NP et al.. 2018. Current knowledge on exosome biogenesis and release.. Cell Mol Life Sci 75(2):193-208 PMID: 28733901
- 5. Garner RT et al.. 2020. Multivesicular body and exosome pathway responses to acute exercise.. Exp Physiol 105(3):511-521 PMID: 31917487
- 6. Lee YJ et al.. 2023. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.. Dev Cell 58(4):320-334.e8 PMID: 36800996
- 7. Henne WM et al.. 2011. The ESCRT pathway.. Dev Cell 21(1):77-91 PMID: 21763610
- 8. Zhao GN et al.. 2017. Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.. Nat Med 23(6):742-752 PMID: 28481357
